Evidence map›Paper›PMID 28806488›Full record

ArticleBritish journal of pharmacology2017

The role of 5-HT

Estelle Ayme-Dietrich, Roland Lawson, Francine Côté, Claudia de Tapia, Sylvia Da Silva, Claudine Ebel, Béatrice Hechler, Christian Gachet, Jérome Guyonnet, Hélène Rouillard and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Tryptophan's Journey Through Pregnancy: The Role of Serotonin.International journal of tryptophan research : IJTR · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Synergistic Interaction of 5-HTInternational journal of molecular sciences · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. First quantitative dosages: Strong correlations between non-5-HTFrontiers in cardiovascular medicine · 2022
    Article
  16. Evaluation of a 5-HTScientific reports · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Estelle Ayme-DietrichLaboratoire de Neurobiologie et Pharmacologie Cardiovasculaire (EA7296), Faculté de Médecine, Fédération de Médecine Translationnelle, Université et Centre Hospitalier de Strasbourg, Strasbourg, France.ORCID http://orcid.org/0000-0002-0613-3803
Roland LawsonLaboratoire de Neurobiologie et Pharmacologie Cardiovasculaire (EA7296), Faculté de Médecine, Fédération de Médecine Translationnelle, Université et Centre Hospitalier de Strasbourg, Strasbourg, France.
Francine CôtéDepartment of Hematology, Institut Imagine, INSERM U1183 CNRS ERL 8254, Université Paris Descartes-Sorbonne Paris Cité, Hôpital Universitaire Necker Enfants Malades, Paris, France.
Claudia de TapiaLaboratoire de Neurobiologie et Pharmacologie Cardiovasculaire (EA7296), Faculté de Médecine, Fédération de Médecine Translationnelle, Université et Centre Hospitalier de Strasbourg, Strasbourg, France.
Sylvia Da SilvaLaboratoire de Neurobiologie et Pharmacologie Cardiovasculaire (EA7296), Faculté de Médecine, Fédération de Médecine Translationnelle, Université et Centre Hospitalier de Strasbourg, Strasbourg, France.
Claudine EbelDepartment of Flow Cytometry, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
Béatrice HechlerEtablissement Français du sang (EFS) Alsace, Inserm U949, Strasbourg, France.
Christian GachetEtablissement Français du sang (EFS) Alsace, Inserm U949, Strasbourg, France.
Jérome GuyonnetPharmaceutical Research Department, CEVA Santé Animale, Libourne, France.
Hélène RouillardLaboratoire de Pathologie, Centre Hospitalier Emile Muller, Mulhouse, France.
Jordane StoltzLaboratoire de Pathologie, Centre Hospitalier Emile Muller, Mulhouse, France.
Emily QuentinINSERM UMR-S 839, Paris, France.
Sophie BanasINSERM UMR-S 839, Paris, France.
François DaubeufLaboratoire d'Innovation Thérapeutique, UMR7200 CNRS/Université de Strasbourg, LabExMedalis, Faculté de Pharmacie, Illkirch, France.
Nelly FrossardLaboratoire d'Innovation Thérapeutique, UMR7200 CNRS/Université de Strasbourg, LabExMedalis, Faculté de Pharmacie, Illkirch, France.
Bernard GasserLaboratoire de Pathologie, Centre Hospitalier Emile Muller, Mulhouse, France.
Jean-Philippe MazzucotelliService de Chirurgie Cardiaque, Centre Hospitalier de Strasbourg, Strasbourg, France.
Olivier HermineDepartment of Hematology, Institut Imagine, INSERM U1183 CNRS ERL 8254, Université Paris Descartes-Sorbonne Paris Cité, Hôpital Universitaire Necker Enfants Malades, Paris, France.
Luc MaroteauxINSERM UMR-S 839, Paris, France.
Laurent MonassierLaboratoire de Neurobiologie et Pharmacologie Cardiovasculaire (EA7296), Faculté de Médecine, Fédération de Médecine Translationnelle, Université et Centre Hospitalier de Strasbourg, Strasbourg, France.
Inserm · FRUniversité de Strasbourg · FRCentre Hospitalier de Mulhouse · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRDépartement Santé Animale · FRHôpital Civil, Strasbourg · FRInstitut de génétique et de biologie moléculaire et cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeValvular heart disease (VHD) is highly prevalent in industrialized countries. Chronic use of anorexigens, amphetamine or ergot derivatives targeting the 5-HT system is associated with VHD. Here, we investigated the contribution of 5-HT receptors in a model of valve degeneration induced by nordexfenfluramine, the main metabolite of the anorexigens, dexfenfluramine and benfluorex. EXPERIMENTAL APPROACH: Nordexfenfluramine was infused chronically (28 days) in mice ((WT and transgenic Htr KEY

resultsChronic treatment of mice with nordexfenfluramine activated 5-HT CONCLUSIONS AND IMPLICATIONS: BM-derived endothelial progenitor cells make a crucial contribution to the remodelling of mitral valve tissue. Our data describe a new and important mechanism underlying human VHD.

Indexed as

Endothelial Progenitor CellsAnimalsBone Marrow TransplantationHeart Valve DiseasesMaleMice, TransgenicMitral ValveNorfenfluramineReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2BSerotonin 5-HT2 Receptor AntagonistsNorfenfluramineReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2BSerotonin 5-HT2 Receptor Antagonists

Identifiers

PMID28806488
PMCPMC5680644
OpenAlexW2749986679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.